BamSEC and AlphaSense Join Forces
Learn More

Standard BioTools Inc.

NASDAQ: LAB    
Share price (11/21/24): $1.62    
Market cap (11/21/24): $603 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 8-K 17 pages Standard BioTools Inc. 2024 Change of Control and Severance Plan and Summary Plan Description Adopted August 27, 2024
12/34/56
EX-10.2
from 10-Q 3 pages Standard BioTools Inc. Nonemployee Director Compensation Policy
12/34/56
EX-10.1
from 8-K 17 pages Standard BioTools Inc. Equity Incentive Plan
12/34/56
EX-10.96
from 10-K/A 2 pages Standard BioTools Inc. Nonemployee Director Compensation Policy
12/34/56
EX-10.1
from 8-K 17 pages Exchange Agreement
12/34/56
EX-10.96
from 10-K 3 pages Standard BioTools Inc. Outside Director Equity Compensation Policy
12/34/56
EX-10.2
from 10-K 14 pages Standard BioTools Inc. Indemnification Agreement This Indemnification Agreement (“Agreement”) Is Made as of , 2024 by and Between Standard BioTools Inc., a Delaware Corporation (The “Company”), and [Name] (“Indemnitee”). 1. Definitions
12/34/56
EX-10.1
from 8-K 17 pages Standard BioTools Inc. 2011 Equity Incentive Plan
12/34/56
EX-10.1
from S-4 5 pages October 1, 2023 Term
12/34/56
EX-10.11
from 10-Q 4 pages Appendix a Standard BioTools Inc. 2023 Change of Control and Severance Plan Participation Agreement
12/34/56
EX-10.10
from 10-Q 2 pages April 4, 2022 Compensation
12/34/56
EX-10.9
from 10-Q 4 pages Appendix a Standard BioTools Inc. 2023 Change of Control and Severance Plan Participation Agreement
12/34/56
EX-10.3
from 8-K 9 pages Standard BioTools Inc. 2011 Equity Incentive Plan Performance Unit Award Agreement
12/34/56
EX-10.2
from 8-K 4 pages Appendix a Standard BioTools Inc. 2023 Change of Control and Severance Plan Participation Agreement
12/34/56
EX-10.1
from 8-K 13 pages Standard BioTools Inc. 2023 Change of Control and Severance Plan and Summary Plan Description Adopted August 4, 2023
12/34/56
EX-10.1
from 8-K 17 pages Standard BioTools Inc. 2011 Equity Incentive Plan
12/34/56
EX-10.3
from 8-K 15 pages May 10, 2023 This Letter Agreement (This “Agreement”) Sets Forth the Terms and Conditions Relating to Certain Benefits That You May Become Eligible to Receive in the Event of Your Termination of Employment From Standard BioTools Inc. (The “Company”). for Valuation Consideration, the Receipt and Sufficiency of Which Are Hereby Acknowledged, and Intending to Be Legally Bound Hereby, the Company and You Hereby Agree as Follows
12/34/56
EX-10.2
from 8-K 4 pages Appendix a Standard BioTools Inc. 2020 Change of Control and Severance Plan Participation Agreement
12/34/56
EX-10.1
from 8-K 3 pages Join an Innovative Team Driven by a Bold Vision – Unleashing Tools to Accelerate Breakthroughs in Human Health May 9, 2023
12/34/56
EX-10.1
from 10-Q 16 pages Material contract
12/34/56